09:53 AM EDT, 07/02/2025 (MT Newswires) -- Inspira Technologies (IINN) said Wednesday it has secured a binding $22.5 million purchase order for its ART100 system.

The purchase order represents "major commercial inflection point" for the company, Inspira said.

The ART100 system is approved for cardiopulmonary bypass in the US and Extracorporeal Membrane Oxygenation procedures outside the US, the company said.

Shares of Inspira Technologies rose 9.3% in early Wednesday trading.

Price: 0.88, Change: +0.07, Percent Change: +8.13